Investors

Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.

Stock Quote
NASDAQ: AZTA
Change:
Volume:
Market Cap:
Recent News
Nov 04, 2024

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes. The Company...

Nov 04, 2024

William L. Cornog, Quentin Koffey and Alan J. Malus Add Deep Industry Expertise and Track Records of Shareholder Value Creation to the Board Establishes Value Creation Committee of the Board...

Oct 30, 2024

Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain...

All Releases

Featured Events
LEARN MORE ABOUT
AZENTA LIFE SCIENCES
Contact Investor Relations

Investor Relations
ir@azenta.com

Sherry Dinsmore
Executive Assistant to CFO
sherry.dinsmore@azenta.com

Transfer Agent:

Computershare
P.O. Box 43006                                   
Providence RI 02940-3006                   
Investor Center web address:
https://www-us.computershare.com/investor

SIGN UP FOR ALERTS AND NEVER MISS INVESTOR UPDATES!

Subscribe

©2024 Azenta, Inc. All rights reserved. | Privacy & Security Policy
Loading data...